Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial. [electronic resource]
Producer: 20140218Description: 679-81 p. digitalISSN:- 1758-1052
- Anti-HIV Agents -- administration & dosage
- CD4 Lymphocyte Count
- Darunavir
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- administration & dosage
- HIV-1 -- drug effects
- Humans
- Ritonavir -- administration & dosage
- Sulfonamides -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.